Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
Year: 2000
Type: article
Study design: Observational Study
Abstract: BRCA1/2 mutation carriers diagnosed with breast cancer have a strongly elevated life-time risk of developing a contralateral tumour. We studied the contralateral breast cancer risk in 164 patients from 83 families with a proven BRCA1 mutation in relation to the age at diagnosis of the first primary breast cancer. In the actuarial outcomes after 10 years' follow-up, 40% of the 124 BRCA1-patients diagnosed with breast cancer < 50 years had developed contralateral breast cancer, vs 12% of the 40 patients > 50 years at first diagnosis (Plogrank = 0.02). These data suggest that age at diagnosis of the first tumour should be taken into account when prophylactic mastectomy in BRCA1-patients is considered.
Source: British Journal of Cancer
Institutions: Erasmus MC, Daniel den Hoed Kliniek, Erasmus University Rotterdam
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $5,190
Funder: KWF Kankerbestrijding
OpenAlex ID: W1605263017
